Population pharmacokinetics of nadroparin for thromboprophylaxis in COVID‐19 intensive care unit patients

AIMS: Nadroparin is administered to COVID‐19 intensive care unit (ICU) patients as thromboprophylaxis. Despite existing population pharmacokinetic (PK) models for nadroparin in literature, the population PK of nadroparin in COVID‐19 ICU patients is unknown. Moreover, optimal dosing regimens achievin...

Descripción completa

Detalles Bibliográficos
Autores principales: Romano, Lorenzo G. R., Hunfeld, Nicole G. M., Kruip, Marieke J. H. A., Endeman, Henrik, Preijers, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878197/
https://www.ncbi.nlm.nih.gov/pubmed/36495312
http://dx.doi.org/10.1111/bcp.15634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878197/
https://www.ncbi.nlm.nih.gov/pubmed/36495312
http://dx.doi.org/10.1111/bcp.15634

Ejemplares similares